Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haferlach

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Der Pathologe|October 23, 2012
[Diagnostics of acute leukemias: interaction of phenotypic and genetic methods]U Bacher, C Haferlach, S Schnittger, et al.
Leukemia|July 29, 2017
Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AMLA Stengel, W Kern, M Meggendorfer, et al.
Bone Marrow Transplantation|April 14, 2009
Interactive diagnostics in the indication to allogeneic SCT in AMLU Bacher, C Haferlach, S Schnittger, et al.
Leukemia|January 15, 2011
Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasmsS Schnittger, U Bacher, C Haferlach, et al.
Leukemia|May 1, 2013
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutationsM Meggendorfer, U Bacher, T Alpermann, et al.
Leukemia|October 10, 2008
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotypeF Dicker, H Herholz, S Schnittger, et al.
Leukemia|January 10, 2014
High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcomeM-T Krauth, C Eder, T Alpermann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2016
Newly acquired kiwi fruit allergy after bone marrow transplantation from a kiwi-allergic donorN Garzorz, J Thomas, B Eberlein, et al.
Leukemia|January 22, 2011
Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedureV Grossmann, A Kohlmann, H-U Klein, et al.
Leukemia|August 21, 2013
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant diseaseA Kohlmann, N Nadarajah, T Alpermann, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Der Pathologe|October 23, 2012
[Diagnostics of acute leukemias: interaction of phenotypic and genetic methods]U Bacher, C Haferlach, S Schnittger, et al.
Leukemia|July 29, 2017
Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AMLA Stengel, W Kern, M Meggendorfer, et al.
Bone Marrow Transplantation|April 14, 2009
Interactive diagnostics in the indication to allogeneic SCT in AMLU Bacher, C Haferlach, S Schnittger, et al.
Leukemia|January 15, 2011
Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasmsS Schnittger, U Bacher, C Haferlach, et al.
Leukemia|May 1, 2013
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutationsM Meggendorfer, U Bacher, T Alpermann, et al.
Leukemia|October 10, 2008
The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotypeF Dicker, H Herholz, S Schnittger, et al.
Leukemia|January 10, 2014
High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcomeM-T Krauth, C Eder, T Alpermann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2016
Newly acquired kiwi fruit allergy after bone marrow transplantation from a kiwi-allergic donorN Garzorz, J Thomas, B Eberlein, et al.
Leukemia|January 22, 2011
Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedureV Grossmann, A Kohlmann, H-U Klein, et al.
Leukemia|August 21, 2013
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant diseaseA Kohlmann, N Nadarajah, T Alpermann, et al.
Pageof 5